Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial
FI: 4,2
Tipo: Article
Colaboración
Año: 2023
Autores
Trigo-Rodríguez, M; Cárcel, S; Navas, A; Espíndola-Gómez, R; Garrido-Gracia, JC; Moreno, MAE; León-López, R; Pérez-Crespo, PMM; Alonso, EA; Vinuesa, D; Romero-Palacios, A; Pérez-Camacho, I; Gutiérrez-Gutiérrez, B; Martínez-Marcos, FJ; Fernández-Roldán, C;
Revista
Título: OPEN FORUM INFECTIOUS DISEASES
Cuartil
- Q3